Tirzepatide
Mounjaro / Zepbound
Tirzepatide
Mounjaro / Zepbound
Select Option
$140.00 each
About Tirzepatide
Tirzepatide is a synthetic 39-amino-acid peptide that acts as a dual agonist at the GLP-1 and GIP receptors. It is one of the most extensively published incretin compounds in current metabolic research and is widely studied for its effects on incretin signaling, glucose homeostasis, and energy balance in preclinical and clinical models. Supplied as a lyophilized powder with a batch-specific certificate of analysis. For laboratory research use only. Not for human consumption.
Research Highlights
- Dual GLP-1 and GIP receptor agonist
- Extensive body of peer-reviewed literature
- Studied in incretin signaling and glucose homeostasis models
- Lyophilized powder for long-term stability
- Third-party tested for identity and purity (≥98%)
- Batch-specific COA supplied with every vial
Reconstitution & Handling
- 1Supplied as a sterile lyophilized powder in a sealed vial
- 2Reconstitute with bacteriostatic water; add solvent slowly along the vial wall and swirl gently — do not shake
- 3Reference concentration: 30mg vial + 3mL solvent yields 10mg/mL
- 4Allow the powder to dissolve fully before use; solution should be clear and colorless
- 5Store reconstituted solution refrigerated at 2–8°C and use within 28 days
- 6Record lot number and reconstitution date for research documentation
Observations Reported in Literature
- •Gastrointestinal effects (nausea, diarrhea, constipation) are the most frequently reported in clinical literature
- •Abdominal discomfort
- •Injection-site reactions
- •Fatigue
Summarized from published research for reference only. This product is not for human consumption.
Storage Instructions
Store lyophilized vials refrigerated between 36-46°F (2-8°C). Do not freeze. Protect from light.
Certificate of Analysis
Every batch is independently tested for identity, purity, and potency. Contact us for COA documentation on any specific batch.
Request Lab Results